| pubmed-article:8582425 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8582425 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:8582425 | lifeskim:mentions | umls-concept:C0521018 | lld:lifeskim |
| pubmed-article:8582425 | lifeskim:mentions | umls-concept:C0439660 | lld:lifeskim |
| pubmed-article:8582425 | lifeskim:mentions | umls-concept:C0036983 | lld:lifeskim |
| pubmed-article:8582425 | lifeskim:mentions | umls-concept:C0272242 | lld:lifeskim |
| pubmed-article:8582425 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:8582425 | pubmed:dateCreated | 1996-3-21 | lld:pubmed |
| pubmed-article:8582425 | pubmed:abstractText | We evaluated the complement system in 29 children (mean age: 4.5 years) who survived fulminant meningococcal septic shock. No terminal complement deficiencies were found. One patient, who experienced the most dramatic disease course, had a decreased haemolytic activity in the haemolysis-in-gel test for the alternative pathway. The properdin concentration in serum of this patient was < 0.1 microgram/ml (n = 17.1-27.7 micrograms/ml). Coagulation studies revealed a heterozygeous type I protein C deficiency as well. He was the only patient with a Neisseria meningitidis group Y infection. CONCLUSION: Fulminant meningococcal disease due to uncommon serogroups should lead to screening of the alternative pathway of complement activation. | lld:pubmed |
| pubmed-article:8582425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582425 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8582425 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582425 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8582425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582425 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8582425 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:8582425 | pubmed:issn | 0340-6199 | lld:pubmed |
| pubmed-article:8582425 | pubmed:author | pubmed-author:DankertJJ | lld:pubmed |
| pubmed-article:8582425 | pubmed:author | pubmed-author:DuN ZNZ | lld:pubmed |
| pubmed-article:8582425 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:8582425 | pubmed:author | pubmed-author:KuijperE JEJ | lld:pubmed |
| pubmed-article:8582425 | pubmed:author | pubmed-author:FijenC ACA | lld:pubmed |
| pubmed-article:8582425 | pubmed:author | pubmed-author:DerkxH HHH | lld:pubmed |
| pubmed-article:8582425 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8582425 | pubmed:volume | 154 | lld:pubmed |
| pubmed-article:8582425 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8582425 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8582425 | pubmed:pagination | 735-8 | lld:pubmed |
| pubmed-article:8582425 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:meshHeading | pubmed-meshheading:8582425-... | lld:pubmed |
| pubmed-article:8582425 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8582425 | pubmed:articleTitle | Inherited complement deficiency in children surviving fulminant meningococcal septic shock. | lld:pubmed |
| pubmed-article:8582425 | pubmed:affiliation | University of Amsterdam, Department of Paediatrics, The Netherlands. | lld:pubmed |
| pubmed-article:8582425 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8582425 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8582425 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8582425 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8582425 | lld:pubmed |
